China is key market for Singaporean biotech start-up's stomach cancer early diagnosis kit

Mainland China will become the largest single market for Singaporean diagnostics start-up Mirxes' core product, a stomach cancer detection kit that was key to the company's development, according to Zhou Lihan, its CEO and co-founder. The biotechnology firm, which launched the world's first molecular diagnostic kit for early detection of gastric cancer in 2019, refiled its draft prospectus for a Hong Kong initial public offering in April with the target of raising at least US$100 million for a v